Xxera/openscience/retractions

Record #37574

Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial

John McCoy, Andy Goren, Flavio Adsuara Cadegiani, Sergio Vano-Galvan, Kaja Kovacevic, Mirna Situm, Jerry Shapiro, Rodney Sinclair, Antonella Tosti, Andrija Stanimirovic, Daniel Fonseca, Edinete Dorner, Dirce Costa Onety, Ricardo Ariel Zimerman, Carlos Gustavo Wambier

Journal

Frontiers in Medicine

Publisher

Original paper date

Jul 19, 2021

Original DOI

10.3389/fmed.2021.668698

Country

🇧🇷 Brazil

Institution

Applied Biology, Inc. Irvine, CA, United States · Department of Endocrinology, Corpometria Institute, Brasilia, Brazil · Dermatology Department, Ramón y Cajal Hospital, Madrid, Spain · Department of Dermatology and Venereology, University Hospital Center “Sestre Milosrdnice”, Zagreb, Croatia · Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, United States · Sinclair Dermatology, Melbourne, VIC, Australia · Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL, United States · School of Medicine, European University Cyprus, Nicosia, Cyprus · Intensive Care Unit, Samel Hospital, Manaus, Brazil · Hospital da Brigada Militar, Porto Alegre, Brazil · Department of Dermatology, Alpert Medical School of Brown University, Providence, RI, United States

Open access

No

Article type

Broad categories

(HSC) Medicine - Infectious Disease (HSC) Medicine - Pharmacology

Notes from Retraction Watch

see also: https://www.bmj.com/content/375/bmj.n2819

Citation lifecycle

How this paper is being cited

Pre-retraction

13

Same day

0

Post-retraction

28

% post-retraction

68.3%

~26.1 citations/yr before retraction · ~6.0 citations/yr after

— citing papers

Who is still citing this work

Loading…